Gf Fund Management Co. Ltd. Harrow Health, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 911 shares of HROW stock, worth $23,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
911
Previous 748
21.79%
Holding current value
$23,995
Previous $25.1 Million
3.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$104 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$56.6 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$49.8 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$49.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$25.2 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $713M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...